HOME >> BIOLOGY >> NEWS
It's not easy being green

es for more fertile soil.

Harvesting the corn stalks or the cover crop to make cellulosic ethanol also reduces nitrous oxide emissions and reduces overall greenhouse gas levels because the ethanol is used instead of gasoline. But without proper management, harvesting corn stalks also can reduce the amount of organic matter in the soil, which reduces the fertility of the soil over time.

"We need to carefully consider and intelligently manage the entire ethanol production system for long- term sustainability not just focus on pieces of the system," Dale said. "Ethanol is and will be a critical part of reducing our national dependence on oil for liquid fuels. Production technology for both corn and cellulosic ethanol is advancing rapidly. So it's essential that we understand how to improve all portions of the system for maximum environmental benefits."


'"/>

Contact: Bruce Dale
bdale@egr.msu.edu
517-896-7264
Michigan State University
16-Feb-2007


Page: 1 2

Related biology news :

1. Universal flu vaccine being tested on humans
2. Reproductive speed protects large animals from being hunted to extinction
3. DNA layer reduces risk of reserve parts being rejected
4. Are scientists making progress in being able to regenerate bone tissue?
5. Its not easy being green
6. New antibacterials being developed to tackle MRSA superbug
7. Accelerating loss of ocean species threatens human well-being
8. Accelerating loss of ocean species threatens human well-being
9. Fat stem cells being studied as option for breast reconstruction
10. Nanotechnology being used to improve biocompatibility of human prosthetics and implants
11. Progress being made in exploring potential use of stem cells to treat heart disease

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: not easy being green

(Date:2/13/2015)... , Feb. 13, 2015 ACT ... company that aims to transform cancer genomic information ... that the company has raised US$ 8 million in ... Based in Taipei, Taiwan , ... ACTDrug™, ACTOnco™. With the aim to implement next ...
(Date:2/9/2015)... RICHARDSON, Texas , Feb. 9, 2015  Lintec ... novel fabrication methods for carbon nanotube (CNT) macrostructures, including ... Texas at Dallas (UTD). Leveraging the vast ... Tokyo, Japan , Lintec of America ... Richardson, TX , focusing on scaling ...
(Date:2/5/2015)... 2015   Marvin Test Solutions , ... test solutions for military, aerospace, and manufacturing ... TS-323 GENASYS Test Platform to ... is a high-performance PXI-based system designed to ... require performance functional testing. GENASYS features a ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
(Date:2/28/2015)... 2015 Increasing its efforts to resolve the ... first three episodes of The GMO TRUTH podcast on both ... as it continues its mission to discover the truth and ... phase, to “uncover the truth about the GMOs in our ... GMO Truth Podcast is an expansion of the documentary/investigative film-making ...
(Date:2/27/2015)... Calif. , Feb. 27, 2015  Pharmacyclics, ... that longer-term toxicology studies for its newly developed ... or RA, have been completed. The results of ... U.S. Food and Drug Administration. The feedback received ... of the ongoing first-in-human study. Additional preclinical work ...
(Date:2/27/2015)... Halifax, Nova Scotia (PRWEB) February 27, 2015 ... clinical stage vaccine and immunotherapy company, today announced ... approved its application for Fast Track designation and ... DPX-Ebola vaccines, in conjunction with the mutual co-development ... had previously obtained Fast Track designation for the ...
(Date:2/27/2015)... , Feb. 27, 2015  Pfenex Inc. (NYSE ... development of biosimilar therapeutics, today announced that it will ... Marriott Marquis on March 2 nd at 3pm ... on a panel discussing the current state of the ... Biosimilars . For more information on ...
Breaking Biology Technology:The Walk a Mile Project Launches “GMO Truth” Podcast 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3
Cached News: